Group One Trading’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-87,800
| Closed | -$200K | – | 7552 |
|
|
2024
Q2 | $200K | Buy |
87,800
+29,600
| +51% | +$113K | ﹤0.01% | 3383 |
|
|
2024
Q1 | $251K | Buy |
58,200
+44,100
| +313% | +$154K | ﹤0.01% | 3357 |
|
|
2023
Q4 | $43K | Buy |
14,100
+1,100
| +8% | +$2.07K | ﹤0.01% | 5182 |
|
|
2023
Q3 | $18.7K | Buy |
+13,000
| New | +$25.2K | ﹤0.01% | 5930 |
|
|
2023
Q2 | – | Sell |
-100
| Closed | -$268 | – | 8334 |
|
|
2023
Q1 | $268 | Buy |
+100
| New | +$481 | ﹤0.01% | 6975 |
|
|
2022
Q4 | – | Sell |
-7,900
| Closed | -$99K | – | 8283 |
|
|
2022
Q3 | $99K | Buy |
7,900
+5,000
| +172% | +$57.1K | ﹤0.01% | 4790 |
|
|
2022
Q2 | $14K | Sell |
2,900
-7,300
| -72% | -$40.4K | ﹤0.01% | 6572 |
|
|
2022
Q1 | $78K | Sell |
10,200
-5,200
| -34% | -$49.3K | ﹤0.01% | 5737 |
|
|
2021
Q4 | $157K | Sell |
15,400
-6,800
| -31% | -$86.7K | ﹤0.01% | 5331 |
|
|
2021
Q3 | $298K | Buy |
22,200
+5,600
| +34% | +$91.3K | ﹤0.01% | 4753 |
|
|
2021
Q2 | $364K | Sell |
16,600
-7,200
| -30% | -$160K | ﹤0.01% | 4568 |
|
|
2021
Q1 | $573K | Buy |
23,800
+4,300
| +22% | +$99.9K | ﹤0.01% | 3861 |
|
|
2020
Q4 | $351K | Buy |
19,500
+4,500
| +30% | +$67.2K | ﹤0.01% | 3590 |
|
|
2020
Q3 | $173K | Buy |
+15,000
| New | +$248K | ﹤0.01% | 3776 |
|
Group One Trading's GTHX Position: Q2 2024 in Review
Group One Trading sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2024, closing a stake of 228,910 shares — an estimated $874K sold.
Group One Trading first reported a position in GTHX in Q4 2019 and held it in 12 quarters. The position peaked at $1.59M in Q4 2023. 88 funds tracked by Wall St. Rank hold GTHX as of Q2 2024.
- Group One Trading reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Group One Trading sold 228,910 G1 Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $874K.
- Group One Trading first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
- Group One Trading's G1 Therapeutics, Inc. Common Stock position peaked at $1.59M in Q4 2023.
- 88 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2024.
Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.